These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2490322)

  • 41. Major histocompatibility complex influences the development of acute graft-versus-host disease in MHC-matched adult allogeneic bone marrow transplantation.
    Smyth LA; Herrmann RP; Christiansen FT; Hollingsworth PN; Townend DC; Edward E; Dawkins RL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1276-8. PubMed ID: 8442111
    [No Abstract]   [Full Text] [Related]  

  • 42. Reduced incidence of chronic rejection in cyclosporine-treated solid organ recipients with donor antigen-specific hyporeactivity.
    Reinsmoen NL; Hertz MI; Kubo SH; Bolman RM; Matas AJ
    Transplant Proc; 1994 Oct; 26(5):2558-9. PubMed ID: 7940790
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunology. A perfect mismatch.
    Kärre K
    Science; 2002 Mar; 295(5562):2029-31. PubMed ID: 11896262
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of the histocompatibility laboratory in desensitization for transplantation.
    Leffell MS; Zachary AA
    Curr Opin Organ Transplant; 2009 Aug; 14(4):398-402. PubMed ID: 19417655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relevance of minor histocompatibility antigens in solid organ transplantation.
    Dierselhuis M; Goulmy E
    Curr Opin Organ Transplant; 2009 Aug; 14(4):419-25. PubMed ID: 19444105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different features of acute liver allograft rejection, their outcome and possible relationship to HLA-compatibility.
    Gubernatis G; Kemnitz J; Tusch G; Ringe B; Bunzendahl H; Riedel T; Müller R; Pichlmayr R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2213-4. PubMed ID: 2652714
    [No Abstract]   [Full Text] [Related]  

  • 47. Is there hyperacute rejection of the liver?
    Duquesnoy RJ
    Transplant Proc; 1989 Jun; 21(3):3506-7. PubMed ID: 2662499
    [No Abstract]   [Full Text] [Related]  

  • 48. 14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.
    Ozawa M; Terasaki PI; Lee JH; Castro R; Alberu J; Alonso C; Alvarez I; Toledo R; Alvez H; Monterio M; Teixeira J; Campbell P; Ciszek M; Charron D; Gautreau C; Christiansen F; Conca R; Gomez B; Monteon F; Grosse-Wilde H; Heinemann F; Humar I; Kamoun M; Kimball P; Kobayashi T; Kupatawintu P; Leech S; LeFor W; Mehra N; Panigrahi A; Naumova E; Norman D; Piazza A; Poli F; Colombo B; Roy R; Schonemann C; Sireci G; Tanabe K; Ishida H; Van den Berg-Loonen E; Zeevi A
    Tissue Antigens; 2007 Apr; 69 Suppl 1():174-9. PubMed ID: 17445195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Major histocompatibility complex.
    Goust JM
    Immunol Ser; 1993; 58():29-48. PubMed ID: 8424978
    [No Abstract]   [Full Text] [Related]  

  • 50. Immediate rejection of a HLA-A, B compatible, HLA-DR incompatible kidney with a positive donor-recipient B-cell crossmatch.
    Berg B; Möller E
    Scand J Urol Nephrol Suppl; 1980; 54():36. PubMed ID: 7013039
    [No Abstract]   [Full Text] [Related]  

  • 51. [Mechanism of graft rejection].
    Kreisler JM
    An Esp Pediatr; 1989 Sep; 31 Suppl 39():6-11. PubMed ID: 2490332
    [No Abstract]   [Full Text] [Related]  

  • 52. Potential role of a mismatched HLA-specific CTL clone developed pre-transplant in graft rejection following cord blood transplantation.
    Narimatsu H; Murata M; Terakura S; Sugimoto K; Naoe T
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):397-402. PubMed ID: 18342781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific HLA antibody production following renal transplantation.
    Martin S; Dyer PA; Gokal R; Mallick NP; Johnson RW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):898. PubMed ID: 3274885
    [No Abstract]   [Full Text] [Related]  

  • 54. The predictive role of immunologic tests in liver transplant rejection.
    Edwards LC; Nikaein A; Bryan C; Gonwa T; Klintmalm G; Husberg B; White M; Stone MJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2282-3. PubMed ID: 2523601
    [No Abstract]   [Full Text] [Related]  

  • 55. Soluble MHC in allograft recipients.
    Burlingham WJ; Claas FH
    Hum Immunol; 1999 May; 60(5):401-2. PubMed ID: 10447397
    [No Abstract]   [Full Text] [Related]  

  • 56. Advances in corneal transplantation.
    Lindstrom RL
    N Engl J Med; 1986 Jul; 315(1):57-9. PubMed ID: 3520325
    [No Abstract]   [Full Text] [Related]  

  • 57. A new day for Human Immunology.
    Hahn AB
    Hum Immunol; 2016 Oct; 77(10):817. PubMed ID: 27590847
    [No Abstract]   [Full Text] [Related]  

  • 58. Current world literature.
    Curr Opin Organ Transplant; 2012 Aug; 17(4):452-65. PubMed ID: 22790080
    [No Abstract]   [Full Text] [Related]  

  • 59. Increasing relevance of histocompatibility testing in organ transplantation.
    Süsal C
    Curr Opin Organ Transplant; 2013 Aug; 18(4):436-7. PubMed ID: 23774634
    [No Abstract]   [Full Text] [Related]  

  • 60. HLA antibody testing: a tool to facilitate not to prevent organ transplantation.
    Claas FH
    Int J Immunogenet; 2008 Aug; 35(4-5):275-7. PubMed ID: 18988321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.